• Ozempic has been making headlines for its remarkable success in treating obesity and diabetes. • Yet it is just one in a rapidly growing class of drugs called peptide therapeutics that sits between small molecules (like aspirin) and biologics (like antibodies). • A UC Santa Barbara research team has developed a technique for efficiently synthesizing non-natural amino acids and applying them to peptide construction. • They hope that the methodology, published in the Journal of the American Chemical Society, will significantly advance peptide research, giving scientists greater access to amino acids beyond the 22 found in nature.
Article Summaries:
- Scientists at UC Santa Barbara have devised a new method for efficiently synthesizing non‑natural amino acids and incorporating them into peptides. Published in the Journal of the American Chemical Society, the technique expands the available “color palette” of building blocks beyond the 22 naturally occurring amino acids. By enabling rapid production of these synthetic residues, the team aims to accelerate research into peptide therapeutics-an emerging drug class that bridges small molecules and biologics. The advancement could broaden the design space for novel drugs, including treatments for obesity, diabetes, and other diseases.
Sources: